Cover image not available

Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia : a systematic review and economic evaluation

Publication Data

Title Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia : a systematic review and economic evaluation
Contributors E. Loveman, NIHR Evaluation, Trials and Studies Coordinating Centre, NIHR Health Technology Assessment Programme
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA
Publication date 2012
Publication location Perth
Language English

Topics

Chronic myeloid leukemia :: Chemotherapy :: Cost-effectiveness
Protein-tyrosine kinase :: Inhibitors :: Effectiveness
Imatinib :: Effectiveness
Clinical trials :: Great Britain

Catalogue Data

OBNB ID GBB263056
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99419061

ISBD

P1053 xiii, 137 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia : a systematic review and economic evaluation. Published by Prepress Projects Ltd. on behalf of NETSCC, HTA in 2012. Publication and catalogue information, links to buy online and reader comments.